1114 related articles for article (PubMed ID: 32476380)
1. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
[TBL] [Abstract][Full Text] [Related]
2. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
Cavallo F; Chiarelli F
Acta Biomed; 2020 Sep; 91(3):e2020015. PubMed ID: 32921711
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Ouldali N; Pouletty M; Mariani P; Beyler C; Blachier A; Bonacorsi S; Danis K; Chomton M; Maurice L; Le Bourgeois F; Caseris M; Gaschignard J; Poline J; Cohen R; Titomanlio L; Faye A; Melki I; Meinzer U
Lancet Child Adolesc Health; 2020 Sep; 4(9):662-668. PubMed ID: 32622376
[TBL] [Abstract][Full Text] [Related]
4. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease epidemic: pitfalls.
Gallizzi R; Corsello G; Pajno GB
Ital J Pediatr; 2020 Aug; 46(1):121. PubMed ID: 32854742
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and Kawasaki syndrome: should we really be surprised?
Loomba RS; Villarreal E; Flores S
Cardiol Young; 2020 Jul; 30(7):1059-1060. PubMed ID: 32412400
[TBL] [Abstract][Full Text] [Related]
7. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
8. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.
Alizargar J
J Formos Med Assoc; 2020 Nov; 119(11):1713-1714. PubMed ID: 32456973
[No Abstract] [Full Text] [Related]
9. Covid-19 in Peru: from supervised walks for children to the first case of Kawasaki-like syndrome.
Yáñez JA; Alvarez-Risco A; Delgado-Zegarra J
BMJ; 2020 Jun; 369():m2418. PubMed ID: 32571770
[No Abstract] [Full Text] [Related]
10. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.
Licciardi F; Pruccoli G; Denina M; Parodi E; Taglietto M; Rosati S; Montin D
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32439816
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki Disease Features and Myocarditis in a Patient with COVID-19.
Chiu JS; Lahoud-Rahme M; Schaffer D; Cohen A; Samuels-Kalow M
Pediatr Cardiol; 2020 Oct; 41(7):1526-1528. PubMed ID: 32542549
[TBL] [Abstract][Full Text] [Related]
14. Kawasaki-like disease in children with COVID-19: A hypothesis.
Amirfakhryan H
Med Hypotheses; 2020 Oct; 143():110117. PubMed ID: 32721809
[TBL] [Abstract][Full Text] [Related]
15. [Kawasaki disease - a new manifestation of COVID-19 in children].
Jiao FY
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):677-678. PubMed ID: 32669159
[TBL] [Abstract][Full Text] [Related]
16. Editoral commentary: Cardiac involvement in SARS-CoV-2-associated inflammatory syndromes.
Picichè M
Trends Cardiovasc Med; 2020 Oct; 30(7):397-398. PubMed ID: 32763421
[No Abstract] [Full Text] [Related]
17. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
Koné-Paut I; Cimaz R
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32611651
[TBL] [Abstract][Full Text] [Related]
18. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series.
Chiotos K; Bassiri H; Behrens EM; Blatz AM; Chang J; Diorio C; Fitzgerald JC; Topjian A; John ARO
J Pediatric Infect Dis Soc; 2020 Jul; 9(3):393-398. PubMed ID: 32463092
[TBL] [Abstract][Full Text] [Related]
19. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
Roe K
Inflammopharmacology; 2020 Oct; 28(5):1219-1222. PubMed ID: 32638151
[TBL] [Abstract][Full Text] [Related]
20. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno A; Carubbi F; Rodríguez-Carrio J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
